CHINA MEDICAL UNIVERSITY HOSPITAL
🇹🇼Taiwan
World's First HLA-G Targeted Exosome Therapy SOB100 Receives FDA Approval for Phase I Cancer Trials
SOB100, developed by China Medical University Hospital and Shine-On Biomedical, represents the world's first exosome-based drug delivery platform specifically targeting HLA-G for cancer treatment.
Avance Clinical Expands Asia-Pacific Footprint with Four Strategic Partnerships in Taiwan
Avance Clinical, a global Contract Research Organization, has signed Memorandums of Understanding with four premier Taiwanese medical institutions, strengthening its GlobalReady model for biotech companies.
St Vincent's Melbourne and CMUH Forge International Partnerships to Advance Clinical Research
St Vincent's Hospital Melbourne has established a partnership with China's Sichuan Provincial People's Hospital to conduct joint multi-center clinical trials focusing on drugs, medical devices, and digital solutions.